Innate imprinting of transcriptional trajectories governs respiratory TRM fate and persistence

Read full text Summarise with VIRAT
Authors: Hongtae Park, Brock A. Kingstad-Bakke, Thomas Cleven, Cynthia C. Aguilar, Hailey E. Bussan, M. Suresh
Cited by: 0
References: 69

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Respiratory T cell immunity wanes rapidly, and inducing durable mucosal memory remains a major challenge. We demonstrate that precision adjuvant activity, using distinct pattern recognition receptor (PRR) agonists to shape innate inflammation, imprints transcriptional trajectories that govern CD8 T cell fate. Using a nano-emulsion platform, Toll-like receptor (TLR)4 signaling induces neutrophilic inflammation and a C/EBP-NF-κB-HIF program that promotes durable, stem-like type 3 CD127 + tissue-resident memory T cells (T RM s). Conversely, stimulator of interferon genes (STING) drives dendritic cell (DC)-monocytic inflammation and activates an IRF-STAT-T-bet axis that programs attrition-prone type 1 T RM s. We reconcile systemic and tissue divergence models by identifying distinct T RM precursors. During influenza, Ly6C lo PD-1 hi LAG-3 hi CD69 hi precursors differentiate via local reprogramming (tissue divergence). In contrast, vaccination generates Ly6C lo LAG-3 lo CD103 hi precursors in lymph nodes and lungs that bypass inhibitory stages (systemic divergence). Mechanistically, T-bet limits T RM precursor formation and differentiation into long-lived type 3 T RM s. Thus, selecting precision adjuvants that limit T-bet activity is critical for durable mucosal T cell immunity.

Fields of Study & Subjects

T-cell and B-cell Immunology Immunotherapy and Immune Responses Immune responses and vaccinations

Publication details

Journal / source
Cell Reports
Volume
45
Issue
4
Pages
117197–117197
Publication date
25 March 2026
Language
EN